skip to the content

Clinical Trials

Systemic Lupus Erythematosus - Vitamin D3 Study

Effect of Vitamin D3 on the IFNa Signature in Patients with Systemic Lupus Erythematosus (Protocol #ALE02)

Protocol ID

08-109

Protocol Description

The purpose of the study is to find out how vitamin D replacement affects the interferon signature in people with systemic lupus erythematosus (SLE).

Eligibility Criteria

Patients with systemic lupus erythematosus (SLE)

Primary Investigator(s)

  • Cynthia Aranow, MD

Contact Information

Sanita Kandasami
(516) 562-2401
skandasami@nshs.edu

Last Update

April 2, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Lupus:
top
top